| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Evofem Biosciences, Inc. (EVFM) has 0 insiders with recent SEC Form 4 filings, including 3 buys and 10 sells. EVFM is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 12, 2020 | Kamdar Kim P. | Director, 10% Owner | Buy | 5,000 | $2.94 | $14,700.00 | +116.6% | |
| Jun 12, 2020 | File Justin J. | Chief Financial Officer | Buy | 8,500 | $3.14 | $26,690.00 | +3.5% | |
| Jun 5, 2020 | Invesco Ltd. | 10% Owner | Buy | 857,143 | $3.50 | $3,000,000.50 | +6.9% | |
| Jun 4, 2020 | Link Fund Solutions Ltd | 10% Owner | Sell | 9,138,504 | $0.23 | $2,101,855.92 | -100% | |
| May 26, 2020 | Invesco Ltd. | 10% Owner | Sell | 77,090 | $5.76 | $443,955.20 | -0.2% | |
| May 1, 2020 | Culwell Kelly | Chief Medical Officer | Sell | 2,000 | $4.71 | $9,410.00 | -0.5% | |
| Feb 19, 2020 | Culwell Kelly | Chief Medical Officer | Sell | 1,000 | $7.00 | $7,000.00 | -0.5% | |
| Feb 19, 2020 | Barrans Russell | Chief Commercial Officer | Sell | 14,957 | $6.50 | $97,220.50 | -4.3% | |
| Jan 16, 2020 | Barrans Russell | Chief Commercial Officer | Sell | 1,578 | $6.50 | $10,257.00 | -0.8% | |
| Jan 13, 2020 | File Justin J. | Chief Financial Officer | Sell | 1,648 | $6.00 | $9,888.00 | -0.9% |